Skin sparing mastectomy – Reimagining negative pressure in complex cases
Supported by 3M
Thursday, March 24, 2021
18:00 (6:00PM) (AEDT)
|Chairperson||Bruce Mann, Australia|
|18:00-18:25||Salvaging the unsalvageable: Negative pressure wound therapy for severe infection of prosthetic breast reconstruction
Farid Meybodi, Australia
|18:25-18:50||Maximising outcomes in skin-sparing mastectomy
Andrew Ong, Australia
|18:50-19:00||Q & A|
MEET THE FACULTY
|Bruce Mann, Australia||Farid Meybodi, Australia||Andrew Ong, Australia|
Dr Farid Meybodi is a specialist Oncoplastic Breast and Endocrine Surgeon and a Clinical Senior Lecturer at the University of Sydney. From the early days of his practice as a consultant, Farid has been fortunate to be a part of leading national teams in breast cancer management. He is passionate about teaching, research and innovation. His special area of interest is oncoplastic breast surgery and post-mastectomy implant-based breast reconstruction.
Andrew Ong is a VMO breast and endocrine surgeon with an interest in breast ultrasound and oncoplastic breast surgery. He is appointed at Campbelltown Public hospital, Sydney and is head of the breast and endocrine unit. The unit is part of a multidisciplinary breast oncology team at Macarthur Cancer Centre which was voted the best cancer therapy centre in NSW for 2018, the third year in a row. Dr. Ong sees over 100 new breast cancer patient a year and has been a full-time clinician for the last 10 years.
Prof. Bruce Mann is Professor of Surgery at the University of Melbourne and Director of The Breast Service at the Royal Melbourne and Royal Women’s Hospital in Melbourne. He is on the council of Breast SurgANZ, the Scientific Advisory Committee of the ANZ Breast Cancer Trials Group and is past president of the Clinical Oncology Society of Australia. He has been involved in many clinical trials and much clinical and translational research regarding breast cancer, with his main research interest being tailoring treatment to the disease and the patient..